Tan Ruimin, Ge Chen, Wang Jingmei, Yang Zinan, Guo He, Yan Yating, Du Quansheng
School of Clinical Medical, North China University of Science and Technology, Tangshan, Hebei, China.
Critical Care Department, Hebei General Hospital, Shijiazhuang, Hebei, China.
Front Immunol. 2025 Mar 3;16:1552265. doi: 10.3389/fimmu.2025.1552265. eCollection 2025.
Sepsis-induced coagulopathy (SIC) is a complex condition characterized by systemic inflammation and coagulopathy. This study aimed to develop and validate a machine learning (ML) model to predict SIC risk in patients with sepsis.
Patients with sepsis admitted to the intensive care unit (ICU) between March 1, 2021, and March 1, 2024, at Hebei General Hospital and Handan Central Hospital (East District) were retrospectively included. Patients were categorized into SIC and non-SIC groups. Data were split into training (70%) and testing (30%) sets. Additionally, for temporal validation, patients with sepsis admitted between March 1, 2024, and October 31, 2024, at Hebei General Hospital were included. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression. Nine ML algorithms were tested, and model performance was assessed using receiver operating characteristic curve (ROC) analysis, including area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The SHaply Additive Explanations (SHAP) algorithm was used to interpret the best-performing model and visualize key predictors.
Among 847 patients with sepsis, 480 (56.7%) developed SIC. The random forest (RF) model with eight variables performed best, achieving AUCs of 0.782 [95% confidence interval (CI): 0.745, 0.818] in the training set, 0.750 (95% CI: 0.690, 0.809) in the testing set, and 0.784 (95% CI: 0.711, 0.857) in the validation set. Key predictors included activated partial thromboplastin time, lactate, oxygenation index, and total protein.
This ML model reliably predicts SIC risk. SHAP enhances interpretability, supporting early, individualized interventions to improve outcomes in patients with sepsis.
脓毒症诱导的凝血病(SIC)是一种以全身炎症和凝血病为特征的复杂病症。本研究旨在开发并验证一种机器学习(ML)模型,以预测脓毒症患者的SIC风险。
回顾性纳入2021年3月1日至2024年3月1日期间在河北医科大学第一医院和邯郸市中心医院(东区)重症监护病房(ICU)收治的脓毒症患者。将患者分为SIC组和非SIC组。数据被分为训练集(70%)和测试集(30%)。此外,为进行时间验证,纳入了2024年3月1日至2024年10月31日期间在河北医科大学第一医院收治的脓毒症患者。使用最小绝对收缩和选择算子(LASSO)回归及多变量逻辑回归进行特征选择。测试了九种ML算法,并使用受试者操作特征曲线(ROC)分析评估模型性能,包括曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)。使用SHapley加法解释(SHAP)算法解释表现最佳的模型并可视化关键预测因素。
在847例脓毒症患者中,480例(56.7%)发生了SIC。具有八个变量的随机森林(RF)模型表现最佳,在训练集中的AUC为0.782 [95%置信区间(CI):0.745,0.818],在测试集中为0.750(95% CI:0.690,0.809),在验证集中为0.784(95% CI:0.711,0.857)。关键预测因素包括活化部分凝血活酶时间、乳酸、氧合指数和总蛋白。
该ML模型可可靠地预测SIC风险。SHAP增强了可解释性,支持早期个体化干预以改善脓毒症患者的预后。